Milestone

2021-08-31

wOmics GMP factory to be established (560 m²)

2021-06-30

wOmics Diagnostics Laboratory to be established (1100 m²)

2021-06-16

wOmics Service Laboratory to be established (200 m²)

2021-06-05

Westlake Omics and ThermoFisher Scientific Signed MoU

2021-05-29

Westlake Omics and BRUKER Signed MoU

2021-05-28

Westlake Omics and SCIEX Signed MoU

2021-05-12

Angel funding round started

2021-05-10

The space of office extended to 1000+ m²

2021-05-02

wOmics Shanghai Office opened

2021-04-30

Fund raise from Westlake Capital

2021-04-30

50+ full-time employees

2021-04-30

50+ contracts and cooperation deals signed.

2021-04-25

Mini Lab established, including three mass spectrometers

2021-04-22

3 national patents, 4 software copyrights, 20 +know-how

2021-04-15

Officially joined national multi-center clinical prospective trial for thyroid nodule diagnosis

2021-03-22

Clinical Laboratory established

2021-02-28

Seed funds from CD Capital, Gaorong, and GL Ventures.

2020-11-20

Space expanded to 560m²

2020-07-08

Westlake Omics established

Clipboard Image.png


Westlake Omics is committed to making breakthroughs in precision medicine and drug R&D by unwavering focus on critical issues that impact life and health. This vision is driven by AI-empowered high-throughput proteomic analysis of minute amounts of clinical specimens and complementary omic technologies, supported by technological innovation and multi-modal big data.


Each and every team member, solidly grounded in the wOmics ethos, works shoulder to shoulder as life-long learners, dedicated to Life sciences & Medicine towards the overarching goal of enhancing all human well-being, in a wise, motivated, innovative and collaborative manner.


For recruitment, Please contact HR@westlakeomics.com

For business, Please contact hello@westlakeomics.com

For complaints and suggestions, Please contact womics-complaint@westlakeomics.com

Founder

Dr. Guo Tiannan

 

Tiannan received training of clinical medicine(1999-2006) in Tongji Medical College, Huazhong University of Science and Technology, and learned biology (2001-2005) in Wuhan University, before he moved to Singapore for PhD training in cancer proteomics (2008-2012) in the laboratories of Dr. Newman Sze in Nanyang Technological University and Dr.Oi Lian Kon in National Cancer Centre Singapore. In 2012, Tiannan started his postdoctoral training in the laboratory of Dr. Ruedi Aebersold in ETH Zurich.Tiannan moved to Sydney as the Scientific Director of ProCan, group leader of Cancer Proteome, Children’s Medical Research Institute, conjoint senior lecturer in The University of Sydney Medical School, in March 2017. Tiannan joined the Westlake Institute for Advanced Studies, Westlake University in August 2017 as a Tenure Track Assistant Professor. More in www.guomics.com.